S. Picaud - Concepedia

Author

S. Picaud

Also Known As

A. Weiss-Puxbaum, H. Dreyfus, J.E. Bray, Krojer, Tobias, O. Fedorov, Picaud, S, Picaud, Sarah, S. Picaud, S.S. Picaud, Sarah Picaud

186

Publications

11.7K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Ludwig Cancer Research Genomics (United Kingdom)Genomics England University of Toronto

About

S. Picaud is an author at University of Oxford specializing in natural sciences, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	9K
2	Natural Sciences	22	27	4.3K
3	Biochemistry	15	20	1.7K
4	Engineering	6	6	445
5	Public Health	1	1	410

S. Picaud

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
Selective inhibition of BET bromodomains P. Filippakopoulos, Jun Qi, S. Picaud, Nature Bet BromodomainsGeneticsPathogenesisMolecular GeneticsMedicine	2010	4.2K
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family P. Filippakopoulos, S. Picaud, Maria Mangos, Cell Structural BioinformaticsEpigenetic ChangeGeneticsHuman Bromodomain FamilyMolecular Biology	2012	1.7K
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain S. Picaud, Christopher Wells, I. Felletar, Proceedings of the National Academy of Sciences	2013	475
Small-Molecule Inhibition of BRDT for Male Contraception Martin M. Matzuk, Michael R. McKeown, P. Filippakopoulos, Cell SpermatogenesisContraceptive UseTestis BoundaryHormonal ContraceptiveFertility	2012	410
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology Pietro Ciceri, Susanne Müller, Alison O’Mahony, Nature Chemical Biology Molecular PharmacologyMedicinal ChemistryMedicineDual Kinase-bromodomain InhibitorsRational Drug Design	2014	347
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains Duncan A. Hay, Oleg Fedorov, Sarah Martin, Journal of the American Chemical Society Combinatorial ChemistryMolecular BiologyLead IdentificationChemistryChemical Biology	2014	281
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains S. Picaud, David Da Costa, Angeliki Thanasopoulou, Cancer Research Histone ModificationsChemoprevention StrategyBet BrdsMolecular BiologyBet Proteins	2013	244
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy S. Picaud, O. Fedorov, Angeliki Thanasopoulou, Cancer Research	2015	224
3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands David S. Hewings, Minghua Wang, Martin Philpott, Journal of Medicinal Chemistry Histone ModificationsMolecular BiologyOrganic ChemistryChemical BiologyMolecular Pharmacology	2011	222
Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit Paul V. Fish, P. Filippakopoulos, Gerwyn Bish, Journal of Medicinal Chemistry Histone ModificationsPharmaceutical ScienceDrug TargetBioorganic ChemistryFragment-derived Hit	2012	195

Page 1